Voloridge Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-170,838	Closed	-$272K	–	1415
2023 Q1	$272K	Sell	170,838 -508,692	-75%	-$2.63M	﹤0.01%	1284
2022 Q4	$4.23M	Buy	+679,530	New	+$4.86M	0.02%	704
2022 Q3	–	Sell	-137,744	Closed	-$876K	–	1451
2022 Q2	$876K	Sell	137,744 -400,112	-74%	-$2.27M	﹤0.01%	1219
2022 Q1	$2.5M	Sell	537,856 -104,179	-16%	-$447K	0.01%	875
2021 Q4	$3.21M	Buy	642,035 +385,274	+150%	+$3.08M	0.02%	896
2021 Q3	$3.09M	Buy	256,761 +191,967	+296%	+$2.79M	0.02%	879
2021 Q2	$1.37M	Buy	+64,794	New	+$1.56M	0.01%	1141
2021 Q1	–	Sell	-49,643	Closed	-$1.29M	–	1473
2020 Q4	$1.29M	Buy	+49,643	New	+$1.49M	0.01%	887
2020 Q1	–	Sell	-6,441	Closed	-$384K	–	1175
2019 Q4	$384K	Buy	+6,441	New	+$290K	0.01%	870
2019 Q3	–	Sell	-5,571	Closed	-$259K	–	1111
2019 Q2	$259K	Buy	+5,571	New	+$262K	0.01%	669
2018 Q1	–	Sell	-67,666	Closed	-$4.46M	–	535
2017 Q4	$4.46M	Sell	67,666 -23,814	-26%	-$1.28M	0.1%	221
2017 Q3	$4.58M	Sell	91,480 -9,839	-10%	-$474K	0.1%	194
2017 Q2	$4.69M	Buy	101,319 +43,884	+76%	+$1.61M	0.12%	180
2017 Q1	$2.03M	Buy	+57,435	New	+$1.32M	0.05%	315
2015 Q4	–	Sell	-214,162	Closed	-$5.05M	–	218
2015 Q3	$5.05M	Buy	+214,162	New	+$13.4M	0.24%	110

Other funds holding ESPR